Today: 21 May 2026
Kenvue stock: Options memo spotlights Jan. 29 vote on Kimberly-Clark deal
10 January 2026
1 min read

Kenvue stock: Options memo spotlights Jan. 29 vote on Kimberly-Clark deal

New York, January 9, 2026, 21:05 EST — Market closed.

  • OCC detailed a planned options adjustment related to Kenvue’s upcoming merger with Kimberly-Clark, set for a shareholder vote on Jan. 29
  • Kenvue shares closed at $16.83, slipping roughly 1% after the U.S. market session ended
  • Deal terms suggest Kenvue’s value will continue to mirror Kimberly-Clark’s stock ahead of the vote

The Options Clearing Corporation on Friday announced a planned adjustment for Kenvue Inc. options before the Jan. 29 shareholder vote on the company’s proposed merger with Kimberly-Clark. Kenvue shares last changed hands at $16.83, slipping roughly 1% after U.S. markets closed.

Why it matters now: Kenvue (KVUE) has become a merger-arbitrage play, with investors valuing the stock based on the offer price and the likelihood the deal goes through. The OCC memo dives into that trade but also clarifies what options contracts would actually deliver if the merger closes — Kimberly-Clark shares and cash, not Kenvue stock.

The OCC’s “new deliverable” is straightforward: 14 Kimberly-Clark (KMB) shares plus $350 in cash for every standard 100-share options contract, with cash covering any fractional shares. Given Kimberly-Clark’s last price of $97.92, this puts the value at about $17.82 per Kenvue share—approximately $1 below Kenvue’s last trade.

A filing this week revealed Kenvue informed employees that Kimberly-Clark will keep current salary and target bonus levels steady for at least a year after the deal closes. The company also indicated it doesn’t expect any benefit changes to kick in during 2026, assuming the transaction wraps up in the second half of the year, “as currently anticipated.”

Kimberly-Clark and Kenvue revealed their deal in November, describing it as a merger of consumer health and personal care businesses. “We are excited to bring together two iconic companies to create a global health and wellness leader,” Kimberly-Clark CEO Mike Hsu said then. investors.kenvue.com

Up next, traders have Kimberly-Clark’s earnings set for Jan. 27 on their radar. The report could shake up the stock piece tied to Kenvue and send the merger spread shifting fast. Kimberly-Clark said it expects to release results around 6:30 a.m. EST.

But the spread isn’t guaranteed to tighten. The deal still requires shareholder approval and antitrust sign-offs. An earlier SEC filing sets a deadline in late 2026, with a $1.136 billion termination fee kicking in under some break conditions.

Macro data might stir things up before traders return Monday. The U.S. consumer-price index for December is set to drop on Jan. 13. Meanwhile, a University of Michigan survey revealed consumer sentiment nudged higher in early January but remains pressured by inflation concerns. Kenvue is scheduled to report earnings on Feb. 5, with its stock trading between $14.02 and $25.17 over the past year.

Jan. 29 is the key date for Kenvue shareholders to vote on the merger. If it clears that hurdle, the focus shifts to timing — and how the spread moves as the companies approach the actual closing window.

Stock Market Today

  • SpaceX Set to Go Public: Key Details and Market Impact
    May 20, 2026, 8:02 PM EDT. SpaceX, founded by Elon Musk, is poised to go public, joining hundreds of companies that raised $70 billion in U.S. equity markets last year. Going public means the company will offer shares for sale on stock exchanges, allowing investors to buy ownership stakes. This move could unlock significant capital for SpaceX's ambitious space ventures, while providing early investors a chance to realize gains. The offering is closely watched amid a strong appetite for tech and aerospace stocks, reflecting broader market interest in innovation-driven firms.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Bank of America stock dips after-hours after $3 billion debt call, with earnings next week
Previous Story

Bank of America stock dips after-hours after $3 billion debt call, with earnings next week

Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results
Next Story

Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results

Go toTop